GENORAY in focus amid debate over health insurance coverage for robotic surgery... Could ‘operating-room imaging equipment’ benefit?

[Financial News]  GENORAY, a company specializing in medical imaging diagnostic equipment, is drawing attention amid discussions about health insurance coverage for robotic surgery. This is because the government is examining the possibility of covering robot-assisted surgery, bringing into focus the mid- to long-term growth potential of related medical-device markets, including operating-room imaging equipment and patient monitors.
According to the medical-device industry on the 11th, the Health Insurance Review and Assessment Service has been conducting an internal study since April on the possibility of covering robot-assisted surgery under health insurance. The study is reportedly scheduled for completion this month. However, whether insurance coverage will actually be provided, which conditions would be covered, and the reimbursement rates are all matters requiring further discussion.
GENORAY’s flagship product is a mobile X-ray fluoroscopy system (C-arm) used in orthopedic surgery and various procedures. Its signature product, BELLIGER ACE, is designed to provide high-resolution images and features an integrated design that makes procedures more convenient for medical staff.
C-arms are widely used in orthopedics and pain treatment, where real-time imaging during surgery is needed. The analysis is that if discussions on insurance coverage for robotic surgery lead medical institutions to increase investment in surgical infrastructure, this could create indirect business opportunities for GENORAY as well.
The company has also recently been expanding its business portfolio. Through Infunics, in which it holds a stake, GENORAY is also involved in the patient-monitor business, which tracks patients’ vital signs. In effect, it has built a portfolio that includes both surgical imaging equipment and devices needed in medical settings to monitor patients’ conditions.
GENORAY’s C-arm revenue in the first half of this year was 28 billion won, up 12.9% from the same period a year earlier. 
The medical-device industry is closely watching the impact that discussions on insurance coverage for robotic surgery may have on the broader market for surgery-related equipment. Robotic surgery and conventional image-guided procedures are used in different areas, making it difficult to conclude that there will be direct benefits. However, assessments suggest that growth opportunities for related companies could vary depending on whether medical institutions expand their investment in equipment.
Meanwhile, GENORAY has established a business presence not only in surgical imaging equipment but also in patient monitors. This is because Infunics, in which it holds a stake, sells patient monitors that track patients’ vital signs in real time. Accordingly, GENORAY is broadening its reach into patient monitoring, centered on C-arms used in orthopedic surgery and procedures.
A medical-industry source said, “If discussions on health insurance coverage for robotic surgery lead to increased investment in surgical infrastructure at medical institutions, they could also have a positive impact on demand for surgery-related medical devices, including imaging equipment and patient monitors.” 
[email protected] Kim Gyeong-a Reporter